CSF2 and neoplasm: During tumor progression, MDSCs are recruited and activated by multiple proinflammatory cytokines, such as prostaglandin E2 (PGE2), granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and CCR5, which are released within the TME (15).